Hesperidin
- Generic Name
- Hesperidin
- Drug Type
- Small Molecule
- Chemical Formula
- C28H34O15
- CAS Number
- 520-26-3
- Unique Ingredient Identifier
- E750O06Y6O
- Background
Hesperidin is a flavan-on glycoside found in citrus fruits.
- Associated Conditions
- Capillary fragility, Venous Insufficiency, Vessels; Varicose
Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy
Phase 3
- Conditions
- Vinca Alkaloid Adverse Reaction
- Interventions
- First Posted Date
- 2022-02-17
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 90
- Registration Number
- NCT05243706
Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
Phase 2
Completed
- Conditions
- Covid19AnosmiaFeverShortness of BreathSore ThroatMuscle WeaknessPain, MusclePainHeadachePain, Joint
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-01-20
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Montreal Heart Institute
- Target Recruit Count
- 216
- Registration Number
- NCT04715932
- Locations
- 🇨🇦
Montreal Heart Institute, Montréal, Quebec, Canada
Hesperidin and Diosmin for Treatment of COVID-19
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 100
- Registration Number
- NCT04452799
Effects of Hesperidin on Insulin Sensitivity
- First Posted Date
- 2013-01-23
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT01773486
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
Vascular Effects of Hesperidin in Metabolic Syndrome
Phase 2
- Conditions
- Endothelial DysfunctionMetabolic Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2009-06-17
- Lead Sponsor
- University of Rome Tor Vergata
- Target Recruit Count
- 30
- Registration Number
- NCT00914251
- Locations
- 🇮🇹
University of Rome Tor Vergata, Rome, Italy
Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women
- First Posted Date
- 2006-05-25
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Société des Produits Nestlé (SPN)
- Target Recruit Count
- 110
- Registration Number
- NCT00330096
- Locations
- 🇫🇷
Centre de Recherche en Nutrition Humaine. Laboratoire de Nutrition Humaine, Clermont-Ferrand, Auvergne, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath